Actively Recruiting
Long-term Social and Psychological Effects of NMDAR Autoimmune Encephalitis in Adults
Led by Hospices Civils de Lyon · Updated on 2026-02-17
30
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
NMDA receptor antibody encephalitis is a rare autoimmune neurological condition affecting the central nervous system, causing symptoms like psychosis, memory loss, seizures, and coma during its acute phase. While the acute phase has been well studied since its discovery, the long-term social and psychological impacts on patients, especially young adults around a median age of 21, are not well understood. This research aims to evaluate how this disease affects patients cognitive function and daily social and professional life after the acute phase. Participants in this observational study are adults diagnosed with NMDAR encephalitis who have completed the acute phase of the disease. The study involves completing several quality of life questionnaires that assess fatigue, anxiety, depression, sleep quality, and overall health status. These assessments are done at the time of inclusion to understand the lasting effects of the disease on patients well-being. During the study, patients will complete various cognitive and psychosocial questionnaires such as PREMS, AEPREM, FSS, GAD7, PHQ9, PSQI, and EQ-5D-5L. The researchers will analyze these responses to measure cognitive impairments and psychosocial challenges after the acute illness. The study is observational and does not involve any treatment interventions. Participants can expect to provide information through online questionnaires using a computer and internet connection. The study duration and follow-up details are not specified.
CONDITIONS
Brief Title
Long-term Impact of NMDAR Encephalitis, Level 3
Research Team
J
Jérôme HONNORAT, Pr
C
Chloé BUTTARD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here